prucalopride
product name :prucalopride
structure
cas number: 179474-81-8
molecular formula c18h26cln3o3
molecular weight 367.874
batch no. 201711002
prucalopride(179474-81-8)was a highly selective serotonin receptor agonist which could improve bowel functions,
including number of bowel movements and a range of other constipation symptoms,as well as health-related quality of life and patient satisfaction.the most common adverse events were headache,diarrhoea,nausea,abdominal pain,etc
mete-analysis showed that the efficacy rate was significantly higher in prucalopride(179474-81-8)group (29.2%) than in the placebo group (12.6%, rr=2.37, 95% ci 2.02-2.79, p〈0.001), while it was similar to that of peg 3350+electrolytes group. the incidence rates of headache, dizziness, diarrhea, abdominal pain, and nausea were higher in the prucalopride group than in the placebo group (p≤ 0.05). there were no differences in the incidence of flatulence and prolonged q t interval between the two groups (p〉0.05). conclusion prucalopride is effective in the treatment of cc, with relatively milder and lower incidence of adverse reaction, and it could be a new choice for the treatment of cc.
specification
test item criteria prescribe
------------------------------------------------------------------------------------
characteristics white to off-white powder
water 4.0~6.0%
melting point 100~110
single impurity ≦0.1%
purity ≧99.5%
solvent residue methanol≦0.3%, ethyl alcohol≦0.5% ,thf≦0.072%